IL129623A0 - Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes - Google Patents
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesInfo
- Publication number
- IL129623A0 IL129623A0 IL12962397A IL12962397A IL129623A0 IL 129623 A0 IL129623 A0 IL 129623A0 IL 12962397 A IL12962397 A IL 12962397A IL 12962397 A IL12962397 A IL 12962397A IL 129623 A0 IL129623 A0 IL 129623A0
- Authority
- IL
- Israel
- Prior art keywords
- syndromes
- prevention
- treatment
- related diseases
- derivatives useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK120196 | 1996-10-28 | ||
PCT/DK1997/000481 WO1998018774A1 (en) | 1996-10-28 | 1997-10-28 | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL129623A0 true IL129623A0 (en) | 2000-02-29 |
Family
ID=8102120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12962397A IL129623A0 (en) | 1996-10-28 | 1997-10-28 | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0937059A1 (en) |
JP (1) | JP2001502706A (en) |
AU (1) | AU744403B2 (en) |
CA (1) | CA2269936A1 (en) |
IL (1) | IL129623A0 (en) |
NO (1) | NO992009L (en) |
WO (1) | WO1998018774A1 (en) |
ZA (1) | ZA979643B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998025916A1 (en) * | 1996-12-13 | 1998-06-18 | C & C Research Laboratories | Novel benzopyran derivatives |
KR100615757B1 (en) * | 1998-12-30 | 2006-08-25 | 시그날 파마소티칼 아이엔씨 | Compounds and methods for modulation of estrogen receptors |
CN1261431C (en) * | 2001-01-24 | 2006-06-28 | 奇斯药制品公司 | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
MX2007003216A (en) | 2004-09-21 | 2008-03-10 | Novogen Res Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy. |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
JP4976649B2 (en) * | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ,インク. | Compound |
WO2012061413A2 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
CA2974123C (en) | 2015-02-02 | 2023-08-01 | Mei Pharma, Inc. | Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (en) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Process for the preparation of 3,4-cis-4-aryl-isoflavans |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 IL IL12962397A patent/IL129623A0/en unknown
- 1997-10-28 EP EP97910262A patent/EP0937059A1/en not_active Ceased
- 1997-10-28 CA CA002269936A patent/CA2269936A1/en not_active Abandoned
- 1997-10-28 AU AU47718/97A patent/AU744403B2/en not_active Ceased
- 1997-10-28 JP JP10519940A patent/JP2001502706A/en active Pending
- 1997-10-28 ZA ZA9709643A patent/ZA979643B/en unknown
- 1997-10-28 WO PCT/DK1997/000481 patent/WO1998018774A1/en not_active Application Discontinuation
-
1999
- 1999-04-27 NO NO992009A patent/NO992009L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4771897A (en) | 1998-05-22 |
NO992009D0 (en) | 1999-04-27 |
ZA979643B (en) | 1998-04-28 |
CA2269936A1 (en) | 1998-05-07 |
NO992009L (en) | 1999-06-25 |
JP2001502706A (en) | 2001-02-27 |
AU744403B2 (en) | 2002-02-21 |
WO1998018774A1 (en) | 1998-05-07 |
EP0937059A1 (en) | 1999-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4966497A (en) | Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same | |
HUP9900790A3 (en) | Imidazoquinazoline derivatives | |
ZA9710322B (en) | Process for the preparation of benzyl-ethers. | |
AU8181798A (en) | Adjustable leg | |
ZA984174B (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
EP0990632A4 (en) | Adamantanemethanol derivatives and process for the preparation thereof | |
EP0890599A4 (en) | Polyorganosiloxazanes and process for the preparation thereof | |
IL129623A0 (en) | Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
IL133089A0 (en) | Novel triptolide derivatives useful in the treatment of autoimmune diseases | |
IL129622A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
IL129624A0 (en) | Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
IL129618A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
AU663832B2 (en) | Easy chess-like game | |
IL129626A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
ZA972708B (en) | Pharmaceutical compositions and methods for the manufacture thereof. | |
GB9608657D0 (en) | Novel treatment | |
IL129617A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
GB2322785B (en) | Pasteurizing process | |
HK1004660A1 (en) | Composition for treating hyperosteogeny and process for the preparation thereof | |
GB2302691B (en) | Oxaindene derivatives and process for the preparation thereof | |
AU7639998A (en) | Pyrrolo{2,1,5-cd}indolizine derivatives useful in the prevention or treatment ofestrogen related diseases or syndromes | |
ZA9610708B (en) | Oxaindene derivatives and process for the preparation thereof. | |
ZA984823B (en) | Pyrrolo(2,1,5-cd)indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
ZA984822B (en) | Pyrrolo (2,11,5-cd) indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
ZA975061B (en) | Manufacture of articles. |